Close Menu

Over at Flies & Bikes, GrumpyBob has a post on a perspectives piece from Sydney Brenner in the latest issue of Genetics. "This brief article ... presents an account of the origins of Caenorhabditis elegans research, by the beast's main man," the blogger writes. What he found most interesting was Brenner's view on how the culture of science has shifted in the last several decades.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.